New SPAC: Translational Development Acquisition Corp. Files for $150M IPO
Following a quiet few weeks with no new S-1 registration statements, Translational Development Acquisition Corp. (NASDAQ:TDAC) filed its S-1 last Friday for a $150 million IPO, marking the second and final SPAC to file for an IPO in August. While Translational Development may acquire a business in any industry, its primary focus will be a target inRead More